在HCC中新辅助和辅助系统疗法:目前的状态和未来的未来
Amit G Singal1, Mark Yarchoan2, Adam Yopp3
1Department of Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
Hepatology communications
|June 3, 2024
概括
辅助免疫疗法,如阿特佐利祖马布加贝瓦齐祖马布,在改善手术后早期肝细胞癌 (HCC) 的无复发生存率方面显示出希望. 对新辅助剂的使用和肝移植桥梁的进一步研究是必要的.
科学领域:
- 肝细胞癌 (HCC) 管理管理
- 手术瘤学手术瘤学
- 医学瘤学 医学瘤学
背景情况:
- 手术切除提供了早期HCC的长期存活,但复发仍然是一个挑战.
- 以前的辅助疗法,包括铁氨酸激酶抑制剂,其疗效有限.
- 系统疗法的近期进展,特别是免疫检查点抑制剂,重新激发了对辅助和新辅助策略的兴趣.
研究的目的:
- 审查包括免疫疗法在内的全身疗法在肝细胞癌外科治疗中的演变作用.
- 讨论新辅助免疫治疗的潜力及其作为肝移植的桥梁战略的使用.
- 突出多学科护理在复杂的HCC病例决策中的重要性.
主要方法:
- 审查最近的临床试验数据,包括IMBrave050试验.
- 对HCC中新辅助免疫疗法的新兴证据的分析.
- 在肝移植的背景下对免疫疗法使用的当前数据的评估.
主要成果:
- 辅助性阿特佐利祖马布加贝瓦齐祖马布在高风险的HCC患者手术后的无复发存活率有所改善.
- 早期数据表明,新辅助免疫治疗的反应率很高,尽管需要进行更大规模的试验.
- 免疫疗法是安全的短期桥梁肝移植,但移植后使用是因为拒绝的风险不鼓励.
结论:
- 辅助性和新辅助性免疫疗法代表了有希望的策略,以改善早期HCC的结果.
- 系统疗法可以作为肝移植的有效桥梁选择,需要进一步调查.
- 在HCC管理的复杂环境中,多学科的合作对于优化治疗决策至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514